![]() | Up a level |
Journal Article
Agostinetto, Elisa ORCID: 0000-0003-0295-7511, Ameye, Lieveke, Martel, Samuel, Aftimos, Philippe, Ponde, Noam, Maurer, Christian
ORCID: 0000-0003-4388-5163, El-Abed, Sarra, Wang, Yingbo, Vicente, Malou, Chumsri, Saranya, Bliss, Judith
ORCID: 0000-0001-7957-7424, Kroep, Judith, Colleoni, Marco, Petrelli, Fausto, Del Mastro, Lucia, Moreno-Aspitia, Alvaro, Piccart, Martine, Paesmans, Marianne, de Azambuja, Evandro and Lambertini, Matteo
ORCID: 0000-0003-1797-5296
(2022).
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.
npj Breast Cancer, 8 (1).
BERLIN:
NATURE PORTFOLIO.
ISSN 2374-4677
Ferreira, Arlindo R., Ferreira, Sofia, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Maurer, Christian, Martel, Samuel, Costa, Luis, Ponde, Noam and de Azambuja, Evandro
ORCID: 0000-0001-9501-4509
(2021).
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial.
Eur. J. Cancer, 144.
S. 351 - 360.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
Brandao, Mariana ORCID: 0000-0002-1653-3544, Maurer, Christian, Ziegelmann, Patricia Klarmann, Ponde, Noam F., Ferreira, Arlindo
ORCID: 0000-0002-1567-9322, Martel, Samuel, Piccart, Martine, de Azambuja, Evandro
ORCID: 0000-0001-9501-4509, Debiasi, Marcio and Lambertini, Matteo
ORCID: 0000-0003-1797-5296
(2020).
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis.
ESMO Open, 5 (4).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2059-7029
Maurer, Christian, Ferreira, Arlindo R., Martel, Samuel, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Ponde, Noam, Aftimos, Philippe, de Azambuja, Evandro
ORCID: 0000-0001-9501-4509 and Piccart, Martine
(2018).
Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer.
Breast, 39.
S. 14 - 19.
EDINBURGH:
CHURCHILL LIVINGSTONE.
ISSN 1532-3080
Martel, Samuel, Bruzzone, Marco ORCID: 0000-0002-8821-4542, Ceppi, Marcello
ORCID: 0000-0002-8177-8003, Maurer, Christian, Ponde, Noam Falbel, Ferreira, Arlindo R., Viglietti, Giulia, Del Mastro, Lucia
ORCID: 0000-0002-9546-5841, Prady, Catherine, de Azambuja, Evandro
ORCID: 0000-0001-9501-4509 and Lambertini, Matteo
ORCID: 0000-0003-1797-5296
(2018).
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
Cancer Treat. Rev., 62.
S. 123 - 133.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1532-1967
Poggio, Francesca ORCID: 0000-0002-4518-2827, Bruzzone, Marco
ORCID: 0000-0002-8821-4542, Ceppi, Marcello
ORCID: 0000-0002-8177-8003, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco
ORCID: 0000-0001-7461-023X, Viglietti, Giulia, Del Mastro, Lucia
ORCID: 0000-0002-9546-5841, de Azambuja, Evandro
ORCID: 0000-0001-9501-4509 and Lambertini, Matteo
ORCID: 0000-0003-1797-5296
(2018).
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.
ESMO Open, 3 (4).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2059-7029
Martel, Samuel, Maurer, Christian, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Ponde, Noam and De Azambuja, Evandro
(2017).
Breast cancer treatment-induced cardiotoxicity.
Expert Opin. Drug Saf., 16 (9).
S. 1021 - 1039.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1744-764X